Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Mogamulizumab
Other

Mogamulizumab

Tracked across 1 events · 10 articles · First seen Jun 10, 2026 · Last active Jun 10, 2026

Sentiment
60
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 60
Tech
Kyowa Kirin presents mogamulizumab data
Kyowa Kirin announced new clinical data, patient-reported outcomes, real-world utilization, and comparative-effectiveness models for Mogamulizumab, a drug used to treat relapsed or refractory mycosis fungoides and Sézary syndrome. These findings will be presented at the…
Impact: Mogamulizumab is the drug being highlighted for its potential in treating cutaneous T-cell lymphoma, which could lead to increased adoption and sales.
Jun 10, 2026 · 10 articles
NEWSDESK
Track Mogamulizumab live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.